2020
DOI: 10.1111/hiv.12979
|View full text |Cite
|
Sign up to set email alerts
|

HIV‐associated neurocognitive impairment in stable people living with HIV on ART in rural Tanzania

Abstract: ObjectivesFew studies have assessed cognitive impairment among healthy people living with HIV (PLWH) who are stable on antiretroviral treatment (ART) in sub‐Saharan Africa.MethodsWe conducted a cross‐sectional study among a random sample of stable adult PLWH from rural Tanzania on ART for more than 1 year and without immunological failure or pre‐existing neurological disease. We evaluated the prevalence and risk factors for neurocognitive impairment (NCI), assessed through neuropsychological tests, functional … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(10 citation statements)
references
References 51 publications
(52 reference statements)
0
10
0
Order By: Relevance
“…Estimates of the prevalence of HIV-associated cognitive impairment have varied widely across the continent but are comparable to other world regions ( 16 , 17 ) and have generally decreased as ART became more widely available ( 18 20 ). The prevalence of mild impairment was reported to be between 40 and 55% and moderate to severe impairment between 3 and 25% in two large multi-country cross-sectional and cohort studies using comprehensive neuropsychological test batteries in the African continent [the AIDS Clinical Trials Group 5199 ( 17 , 21 ) and the African Cohort Study ( 22 )], and in several larger studies from South Africa ( 23 ), Malawi ( 24 ), Tanzania ( 25 ) and Zimbabwe ( 26 ). Cognitive development is also impacted in pediatric HIV, where infants and young children with HIV do not perform as well as their HIV-exposed or HIV uninfected peers ( 27 30 ).…”
Section: Clinical Backgroundmentioning
confidence: 99%
“…Estimates of the prevalence of HIV-associated cognitive impairment have varied widely across the continent but are comparable to other world regions ( 16 , 17 ) and have generally decreased as ART became more widely available ( 18 20 ). The prevalence of mild impairment was reported to be between 40 and 55% and moderate to severe impairment between 3 and 25% in two large multi-country cross-sectional and cohort studies using comprehensive neuropsychological test batteries in the African continent [the AIDS Clinical Trials Group 5199 ( 17 , 21 ) and the African Cohort Study ( 22 )], and in several larger studies from South Africa ( 23 ), Malawi ( 24 ), Tanzania ( 25 ) and Zimbabwe ( 26 ). Cognitive development is also impacted in pediatric HIV, where infants and young children with HIV do not perform as well as their HIV-exposed or HIV uninfected peers ( 27 30 ).…”
Section: Clinical Backgroundmentioning
confidence: 99%
“…A total of 22 articles in Africa [9][10][11][12]15,16,[20][21][22][28][29][30][31][32][33][34][35][36][37][38][39][40] that examined NCI and associated factors in 6741 people living with HIV have been included in this study. Regarding the regional distribution, the three articles 16,28,32 were done in Central and South Africa, fifteen 9,11,12,15,[20][21][22][29][30][31][33][34][35]38,40 were from East Africa and four 10,36,37,39 from West Africa.…”
Section: Characteristics Of Studies Includedmentioning
confidence: 99%
“…Based on the study design, 19 9,10,12,15,16,[20][21][22][28][29][30][31][32][33][34][35][38][39][40] of them were cross-sectional, one cohort, 37 and two casecontrol 11,36 studies. More than half of these studies 10,15,16,21,22,28,30,[32][33][34][35][36]38,40 used IHDS to screen NCI among individuals living with HIV.…”
Section: Characteristics Of Studies Includedmentioning
confidence: 99%
See 2 more Smart Citations